STYX and endometrial cancer: have revealed that the serine/threonine/tyrosine interacting protein (STYX) accelerates endometrial cancer cell proliferation and suppresses apoptosis partly through the Notch/mTOR pathway by downregulating the expression of FBXW7 (43).